Skip to content
healthcare.dev

Rugby Chest Congestion Relief PE

NDC 0536-1309, Guaifenesin/phenylephrine, tablet, from Rugby Laboratories.

Product NDC
0536-1309
Status
Listed
Labeler
Rugby Laboratories
Dosage form
TABLET
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
OTC MONOGRAPH DRUG
Application
M012
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0536-1309 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • GUAIFENESIN400 mg/1
  • PHENYLEPHRINE HYDROCHLORIDE10 mg/1

Pharmacologic classes

Adrenergic alpha1-Agonists [MoA]; Decreased Respiratory Secretion Viscosity [PE]; Expectorant [EPC]; Increased Respiratory Secretions [PE]; alpha-1 Adrenergic Agonist [EPC]

Package NDCNDC-11Package
0536-1309-07005361309071 BOTTLE, PLASTIC in 1 CARTON (0536-1309-07) / 30 TABLET in 1 BOTTLE, PLASTIC
0536-1309-08005361309081 BOTTLE, PLASTIC in 1 CARTON (0536-1309-08) / 60 TABLET in 1 BOTTLE, PLASTIC

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • NADAC price for package 00536130908

    GET /v1/drugs/nadac/00536130908

Use it

Look up 0536-1309 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0536-1309 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0536-1309. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.